ROCHELLE LAMB: Open Payments
NPI 1427023837 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 18 payments from 11 companies in 2025. Trend: 2023 $305 · 2024 $59 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $427 |
| Amgen Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 1 | $121 |
| Lilly USA, LLC | 2 | $66 |
| Avita Medical Americas, LLC | 1 | $42 |
| Organogenesis Inc. | 2 | $38 |
| ConvaTec Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $18 |
| STRATA Skin Sciences, Inc. | 1 | $17 |
Products named: Leqselvi, Winlevi, OTEZLA, DUPIXENT, ILUMYA, Rhapsido, EBGLYSS, Recell.
Industry payments across MD — which companies pay providers there.
